APA (7th ed.) Citation

P, V., K, L., D, E., PA, K., & M, E. M. (2014). Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. The Journal of clinical endocrinology and metabolism, 99(2), 387. https://doi.org/10.1210/jc.2013-3031

Chicago Style (17th ed.) Citation

P, Vellanki, Lange K, Elaraj D, Kopp PA, and El Muayed M. "Denosumab for Management of Parathyroid Carcinoma-mediated Hypercalcemia." The Journal of Clinical Endocrinology and Metabolism 99, no. 2 (2014): 387. https://doi.org/10.1210/jc.2013-3031.

MLA (9th ed.) Citation

P, Vellanki, et al. "Denosumab for Management of Parathyroid Carcinoma-mediated Hypercalcemia." The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 2, 2014, p. 387, https://doi.org/10.1210/jc.2013-3031.